entertainment -WSS

entertainment

author：entertainment 2025-09-28 23:47:48 - browse：3

Jakub Porzycki/NurPhoto via AP

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with the fallout from Pfizer’s downbeat update, a new entrant in obesity research, and an orthogonal CRISPR business.

The need-to-know this morning

Apellis Pharmaceuticals said a European advisory committee is expected to recommend against the approval of Syfovre, its eye drug for a common form of blindness. The company plans to appeal the negative ruling.
Sage Therapeutics and Biogen announced the commercial launch of Zurzuvae, an oral treatment for women with postpartum depression.
Merck and Moderna reported three-year follow-up data on their mRNA-based immunotherapy for advanced melanoma. Phase 3 studies are underway.
The FDA accepted Amgen’s marketing application for tarlatamab, a bispecific antibody to treat advanced small cell lung cancer. The approval decision date is June 12, 2024.

Is it time to worry about Moderna?

Yesterday’s news that Pfizer is expecting to sell far fewer Covid-19 vaccines than Wall Street expected sent shares of Moderna down as much as 6% on fears that the company could be in for a painful revision of its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： How CRISPR works, explained in two minutes

knowledge

WSS

As health system earnings go up, health insurance stocks go down

AltruBio raises $225 million to develop ulcerative colitis drug

Has Bernie Sanders reached the limit of his pharma bullying effort?

Judge in Trump's classified documents case questions use of out

HHS's proposed rule does nothing to address the climate crisis

Primary care doctor shortage won't be solved by free med school tuition

hotspot

entertainment

The need-to-know this morning

Is it time to worry about Moderna?

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

Primary care doctor shortage won't be solved by free med school tuition

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Feed a cold, starve a fever? Here’s what science says

Duchenne breakthrough therapy leaves behind pioneering families

Restaurant meals are packed with calories, and we still keep eating them

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Most antidepressants don't work on kids, teens, study finds

Activists slam private health insurers over coverage restrictions

The creative science of coining drug names

explore

Sweden knocks USA out of World Cup in penalty kicks

Election results set back Medicaid expansion plans

Judge in Trump's classified documents case questions use of out

Judge in Trump's classified documents case questions use of out

AltruBio raises $225 million to develop ulcerative colitis drug

Class action alleges UnitedHealth concealed DOJ probe

entertainment

knowledge

leisure time

Wikipedia